YM155 induced autophagy-dependent apoptosis and autophagic cell death through AKT/mTOR pathway, which significantly enhanced the sensitivity of erlotinib to EGFR-TKI resistant NSCLC cells. The gene discussed is MTOR; the disease is non-small cell lung carcinoma.